Loading
AMN Healthcare Services Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 07 Mar 2024.
AMN Healthcare Services Inc: what insiders have been doing
AMN Healthcare Services Inc is a Healthcare & Pharma company. Its directors and officers file their transactions with SEC (Form 4). In the past year (18 October 2025 to 18 October 2026), 27 filings came from 7 insiders.
There is no open-market purchase to report; the filings show 2 sales by 1 insider. The totals exclude 2 filings filed without an amount.
Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
For context, the typical company on the same exchange (median of 5,810 companies) published 19 filings over the same period, against 27 filings here. Since 2016, the database holds 11 purchases and 31 sales by insiders of the company. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported revenue of 2.73 bn USD and net income of -95.7 m USD.
Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Anixa Biosciences Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
173
Thresholds
n/a
Buy Volume
€2M
11 ops. · all time
Sell Volume
€9M
31 ops. · all time
Who traded when
BuySaleMark G. Foletta2 sales
Since the insiders bought
- -56.7%Entry US$60.89 · Close at T+365 US$26.34
- -53.9%Entry US$56.80 · Close at T+365 US$26.16
- -57.6%Entry US$57.93 · Close at T+365 US$24.57
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate AMN Healthcare Services Inc Hold (neutral), based on 7 analysts. Average price target: US$36.57.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 16,560 of 24,148 companies
39.4
score / 100
Value42
Quality37
FCF yld15%
Earn yld-6.1%
EV/EBITDA23.4x
ROE16%
Gross mgn28%
Net mgn-3.5%
Debt/EBITDA7.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$36.54
Analyst consensus
7 analystsHold
US$28.00Target US$36.57(+0%)US$43.00
Income statement
RevenueUS$2.7B
Gross profitUS$774.1M28% margin
EBITDAUS$101.1M4% margin
Net income-US$95.7M3.1% margin
Valuation
PER (trailing)13.6x
PER (forward)38.9x
P/Book1.9x
Beta0.40
Balance sheet & cash
Market capUS$1.4B
Total debtUS$803.2M
Free Cash FlowUS$233.8M
Debt / Equity105%
Profitability & ownership
ROE15.6%
ROA4.4%
% insiders1.0%
% institutions124.9%
Last declaration on 15 October 2026
Declarations173 total
9,331 shares0Common StockSEC:0001628280-26-065973:0
4,976 shares0Common StockSEC:0001628280-26-065972:0
3,348 shares@ US$37.660.0089% mcap5.9% of flowCommon StockSEC:0001628280-26-065973:1
1,212 shares@ US$37.660.0032% mcap31.8% of flowCommon StockSEC:0001628280-26-065972:1
498 shares0Common StockSEC:0001628280-26-062129:0
122 shares@ US$34.190.0003% mcap4.1% of flowCommon StockSEC:0001628280-26-062129:1
8,325 shares0Common StockSEC:0001628280-26-047807:0
1,681 sharesCommon StockSEC:0001628280-26-043718:0
2,000 sharesCommon StockSEC:0001628280-26-043718:1
3,681 shares@ US$31.000.0086% mcap12.0% of flowCommonSEC144:0001969223-26-000704
8,843 shares0Common StockSEC:0001628280-26-004320:0
202 shares0Common StockSEC:0001628280-26-004319:0
1,433 shares0Common StockSEC:0001628280-26-004323:0
1,495 shares@ US$19.552.2% of flowCommon StockSEC:0001628280-26-002540:1
2,713 shares@ US$19.554.1% of flowCommon StockSEC:0001628280-26-002540:3
5,042 shares0Common StockSEC:0001628280-26-002540:0
10,664 shares0Common StockSEC:0001628280-26-002540:2
25,425 shares0Common StockSEC:0001628280-26-002540:4
6,191 shares@ US$19.559.3% of flowCommon StockSEC:0001628280-26-002540:5
202 shares0Common StockSEC:0001628280-26-002302:0
1,433 shares0Common StockSEC:0001628280-26-002280:0
8,843 shares0Common StockSEC:0001628280-26-002278:0
12,212 shares0Common StockSEC:0001628280-25-056991:0
676 shares@ US$17.220.9% of flowCommon StockSEC:0001628280-25-054616:1
1,650 shares@ US$17.222.2% of flowCommon StockSEC:0001628280-25-054616:3
25 of 173 declarations
About AMN Healthcare Services Inc
AMN Healthcare Services, Inc. (ticker: AMN) is a US-listed company on the NYSE in the United States (United States), focused on healthcare workforce solutions and medical staffing. For French-speaking investors, AMN is best understood as an operating partner to hospitals, health systems, clinics, and other care providers that need to recruit, place, and manage clinical and administrative talent in a structurally tight labor market. The company was founded in 1985 and is headquartered in Dallas, Texas. Over time, it has built a broad platform by combining staffing, recruiting, and workflow support capabilities across several healthcare labor categories.
AMN’s business is organized around three core lines. First, nurse and allied solutions, which includes travel nursing and allied health placements for hospitals and other care settings. Second, physician and leadership solutions, which covers locum tenens staffing, physician search, and executive/leadership recruitment. Third, the company’s language services and related technology-enabled offerings, which support communication, scheduling, and operational efficiency in healthcare environments. These services are designed to help clients address staffing shortages, improve fill rates, and manage labor costs more effectively.
Read moreShow less
From a competitive standpoint, AMN is one of the better-known scaled players in US healthcare staffing. Its strengths lie in its national recruiting infrastructure, brand recognition, client relationships, breadth of service categories, and ability to offer integrated workforce solutions rather than a single-point staffing product. In a fragmented industry, scale matters: large hospital systems often prefer vendors that can support multiple staffing needs, data-driven workforce planning, and rapid deployment of talent. AMN therefore competes not only on price, but also on execution, speed, and the ability to deliver specialized clinicians and language support when demand spikes.
Geographically, AMN is primarily exposed to the United States, which is also the key market for its investors. The business is closely tied to US healthcare utilization patterns, hospital budget conditions, and labor availability. Recent company communications in 2024 and 2025 indicate that AMN has been navigating a post-pandemic normalization in temporary staffing while emphasizing profitability discipline, balance sheet improvement, and a gradual shift toward more technology-enabled solutions. Recent results also highlight the importance of physician and leadership services and language services as more stable components of the portfolio. For investors, AMN is a cyclical but strategically relevant healthcare services platform with leverage to long-term shortages in clinical labor and the ongoing need for hospitals to manage workforce complexity.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
